Latanoprost Elvim

Latanoprost, the active ingredient in Latanoprost Elvim, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It is employed to lower intraocular pressure in patients with open‑angle glaucoma or ocular hypertension, helping to protect the optic nerve from damage.

GNH USA supplies Latanoprost Elvim as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory documentation and logistics support for global distribution. The company adheres to stringent quality standards and works with authorized importers to ensure product integrity.

Latanoprost is a prostaglandin analog used to manage conditions that involve elevated intraocular pressure. - Open-angle glaucoma: reduces intraocular pressure to help prevent optic nerve damage. - Ocular hypertension: lowers eye pressure in patients with elevated pressure but no optic nerve damage. - Other forms of glaucoma: provides pressure‑lowering effect in secondary or pigmentary glaucoma when appropriate.

Latanoprost may cause ocular and systemic reactions, most of which are mild and transient.

Common Side Effects: - Eye redness: transient hyperemia of the conjunctiva. - Eye irritation or burning sensation after instillation. - Increased pigmentation of the iris, leading to a gradual darkening. - Growth of eyelashes (hypertrichosis) on the treated eye.

Serious or Rare Side Effects: - Severe allergic reaction with swelling, itching, or rash around the eye. - Persistent eye pain with vision loss indicating possible corneal ulcer. - Inflammation of the anterior chamber (uveitis) that requires medical attention.

When prescribing Latanoprost, clinicians should consider several safety measures to minimize risks. - Monitor intraocular pressure: assess response after initiation and adjust therapy as needed. - Evaluate for ocular infections: avoid use in active conjunctivitis or keratitis. - Assess hypersensitivity: discontinue if patient develops allergic signs. - Caution in pregnancy and lactation: safety category is unknown; use only if benefit outweighs risk. - Inform patients about possible iris color change and eyelash growth. - Store at room temperature: keep in original container, protect from light and moisture.

Latanoprost can interact with other ophthalmic or systemic agents, affecting efficacy or safety.

Major Interactions (Avoid): - Concurrent use of other prostaglandin analog eye drops: may increase risk of ocular irritation. - Use with non‑steroidal anti‑inflammatory eye drops: can reduce Latanoprost’s pressure‑lowering effect.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: additive intraocular pressure reduction may cause hypotony. - Alpha‑agonist eye drops: may increase ocular surface irritation. - Systemic carbonic anhydrase inhibitors: potential for enhanced IOP‑lowering effect. - Anticholinergic agents: may affect tear production, increasing discomfort.